These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 19428102)

  • 1. Identification of annexin 1 as a PU.1 target gene in leukemia cells.
    Iseki Y; Imoto A; Okazaki T; Harigae H; Takahashi S
    Leuk Res; 2009 Dec; 33(12):1658-63. PubMed ID: 19428102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of PU.1 and signal regulatory protein α1 expression in PU.1 transgenic K562 cells.
    Iseki Y; Nakahara M; Kubo M; Obata F; Harigae H; Takahashi S
    Int J Mol Med; 2012 Feb; 29(2):319-23. PubMed ID: 22075620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metallothionein-1 isoforms and vimentin are direct PU.1 downstream target genes in leukemia cells.
    Imoto A; Okada M; Okazaki T; Kitasato H; Harigae H; Takahashi S
    J Biol Chem; 2010 Apr; 285(14):10300-9. PubMed ID: 20139074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse correlation between Flt3 and PU.1 expression in acute myeloblastic leukemias.
    Inomata M; Takahashi S; Harigae H; Kameoka J; Kaku M; Sasaki T
    Leuk Res; 2006 Jun; 30(6):659-64. PubMed ID: 16271760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of PU.1-induced mouse calcium-calmodulin-dependent kinase I-like kinase (CKLiK) on apoptosis of murine erythroleukemia cells.
    Yamada T; Suzuki M; Satoh H; Kihara-Negishi F; Nakano H; Oikawa T
    Exp Cell Res; 2004 Mar; 294(1):39-50. PubMed ID: 14980499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PU.1 silencing leads to terminal differentiation of erythroleukemia cells.
    Atar O; Levi BZ
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1288-92. PubMed ID: 15766566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of PU.1 in the transcriptional regulation of TNF-alpha.
    Fukai T; Nishiyama C; Kanada S; Nakano N; Hara M; Tokura T; Ikeda S; Ogawa H; Okumura K
    Biochem Biophys Res Commun; 2009 Oct; 388(1):102-6. PubMed ID: 19646961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PU.1 and CEBPA expression in acute myeloid leukemia.
    D'Alò F; Di Ruscio A; Guidi F; Fabiani E; Greco M; Rumi C; Hohaus S; Voso MT; Leone G
    Leuk Res; 2008 Sep; 32(9):1448-53. PubMed ID: 18308386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic profiling identifies a PU.1 regulatory network in macrophages.
    Weigelt K; Lichtinger M; Rehli M; Langmann T
    Biochem Biophys Res Commun; 2009 Mar; 380(2):308-12. PubMed ID: 19167354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of c-myc gene accompanied by PU.1 deficiency in radiation-induced acute myeloid leukemia in mice.
    Hirouchi T; Takabatake T; Yoshida K; Nitta Y; Nakamura M; Tanaka S; Ichinohe K; Oghiso Y; Tanaka K
    Exp Hematol; 2008 Jul; 36(7):871-85. PubMed ID: 18375040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spi-1/PU.1 but not Fli-1 inhibits erythroid-specific alternative splicing of 4.1R pre-mRNA in murine erythroleukemia cells.
    Théoleyre O; Deguillien M; Morinière M; Starck J; Moreau-Gachelin F; Morlé F; Baklouti F
    Oncogene; 2004 Jan; 23(4):920-7. PubMed ID: 14647452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PU.1, a novel caspase-3 substrate, partially contributes to chemotherapeutic agents-induced apoptosis in leukemic cells.
    Zhao M; Duan XF; Wen DH; Chen GQ
    Biochem Biophys Res Commun; 2009 May; 382(3):508-13. PubMed ID: 19281794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PU.1: a crucial and versatile player in hematopoiesis and leukemia.
    Kastner P; Chan S
    Int J Biochem Cell Biol; 2008; 40(1):22-7. PubMed ID: 17374502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between the homeodomain protein HOXC13 and ETS family transcription factor PU.1 and its implication in the differentiation of murine erythroleukemia cells.
    Yamada T; Shimizu T; Suzuki M; Kihara-Negishi F; Nanashima N; Sakurai T; Fan Y; Akita M; Oikawa T; Tsuchida S
    Exp Cell Res; 2008 Feb; 314(4):847-58. PubMed ID: 18076876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purine-rich box-1-mediated reduced expression of CD20 alters rituximab-induced lysis of chronic lymphocytic leukemia B cells.
    Mankaï A; Bordron A; Renaudineau Y; Martins-Carvalho C; Takahashi S; Ghedira I; Berthou C; Youinou P
    Cancer Res; 2008 Sep; 68(18):7512-9. PubMed ID: 18794139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of the Spi-1/PU.1 oncogene induces the expression of TRIM10/HERF1, a key factor required for terminal erythroid cell differentiation and survival.
    Blaybel R; Théoleyre O; Douablin A; Baklouti F
    Cell Res; 2008 Aug; 18(8):834-45. PubMed ID: 18560381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The differentiating and apoptotic effects of 2-aza-5'-deoxycytidine are dependent on the PU.1 expression level in PU.1-transgenic K562 cells.
    Aoyama S; Nakano H; Danbara M; Higashihara M; Harigae H; Takahashi S
    Biochem Biophys Res Commun; 2012 Apr; 420(4):775-81. PubMed ID: 22459451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of the PU.1 Ets domain are specifically associated with murine radiation-induced, but not human therapy-related, acute myeloid leukaemia.
    Suraweera N; Meijne E; Moody J; Carvajal-Carmona LG; Yoshida K; Pollard P; Fitzgibbon J; Riches A; van Laar T; Huiskamp R; Rowan A; Tomlinson IP; Silver A
    Oncogene; 2005 May; 24(22):3678-83. PubMed ID: 15750630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.
    Huang G; Zhang P; Hirai H; Elf S; Yan X; Chen Z; Koschmieder S; Okuno Y; Dayaram T; Growney JD; Shivdasani RA; Gilliland DG; Speck NA; Nimer SD; Tenen DG
    Nat Genet; 2008 Jan; 40(1):51-60. PubMed ID: 17994017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of PU.1 in mouse adar-1 gene transcription induced by high-dose esiRNA.
    Wu T; Zhao Y; Hao Z; Zhao H; Wang W
    Int J Biol Macromol; 2009 Aug; 45(2):157-62. PubMed ID: 19422845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.